Structure Therapeutics (GPCR) Accumulated Depreciation (2022 - 2025)

Structure Therapeutics' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 81.48% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 81.48% YoY), while the FY2025 annual figure was $3.0 million, up 81.48% from the prior year.
• Accumulated Depreciation for Q4 2025 stood at $3.0 million, up from $1.6 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $3.0 million in Q4 2025, with the low at $349000.0 in Q4 2022.
• The 4-year median for Accumulated Depreciation is $755000.0 (2023), against an average of $1.0 million.
• The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation soared 154.04% in 2024, then jumped 81.48% in 2025.
• Structure Therapeutics' Accumulated Depreciation stood at $349000.0 in 2022, then jumped by 84.53% to $644000.0 in 2023, then soared by 154.04% to $1.6 million in 2024, then surged by 81.48% to $3.0 million in 2025.
• Business Quant data shows GPCR's Accumulated Depreciation at $3.0 million in Q4 2025, $1.6 million in Q4 2024, and $1.4 million in Q3 2024.